| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 3686827
[patent_doc_number] => 05663168
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-09-02
[patent_title] => 'Use of compositions for combating tumour diseases'
[patent_app_type] => 1
[patent_app_number] => 8/242915
[patent_app_country] => US
[patent_app_date] => 1994-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17654
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 382
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/663/05663168.pdf
[firstpage_image] =>[orig_patent_app_number] => 242915
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/242915 | Use of compositions for combating tumour diseases | May 15, 1994 | Issued |
Array
(
[id] => 3695880
[patent_doc_number] => 05618831
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-04-08
[patent_title] => 'Composition and method for treating cancer'
[patent_app_type] => 1
[patent_app_number] => 8/242834
[patent_app_country] => US
[patent_app_date] => 1994-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6688
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 274
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/618/05618831.pdf
[firstpage_image] =>[orig_patent_app_number] => 242834
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/242834 | Composition and method for treating cancer | May 15, 1994 | Issued |
| 08/243595 | THERAPEUTIC REGIMEN FOR TREATING PATIENTS WITH TAXOL | May 15, 1994 | Abandoned |
| 08/240648 | COMBINATION CHEMOTHERAPY | May 12, 1994 | Abandoned |
Array
(
[id] => 3758273
[patent_doc_number] => 05721242
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-02-24
[patent_title] => 'Antibiotic combination'
[patent_app_type] => 1
[patent_app_number] => 8/241887
[patent_app_country] => US
[patent_app_date] => 1994-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1601
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/721/05721242.pdf
[firstpage_image] =>[orig_patent_app_number] => 241887
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/241887 | Antibiotic combination | May 11, 1994 | Issued |
Array
(
[id] => 3487940
[patent_doc_number] => 05426123
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-06-20
[patent_title] => 'Method for lowering serum cholesterol with 1,1,2-triphenylbut-1-ene derivatives'
[patent_app_type] => 1
[patent_app_number] => 8/241262
[patent_app_country] => US
[patent_app_date] => 1994-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2562
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/426/05426123.pdf
[firstpage_image] =>[orig_patent_app_number] => 241262
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/241262 | Method for lowering serum cholesterol with 1,1,2-triphenylbut-1-ene derivatives | May 10, 1994 | Issued |
Array
(
[id] => 3665738
[patent_doc_number] => 05597829
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-01-28
[patent_title] => 'Lactone stable formulation of camptothecin and methods for uses thereof'
[patent_app_type] => 1
[patent_app_number] => 8/240035
[patent_app_country] => US
[patent_app_date] => 1994-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12798
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 24
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/597/05597829.pdf
[firstpage_image] =>[orig_patent_app_number] => 240035
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/240035 | Lactone stable formulation of camptothecin and methods for uses thereof | May 8, 1994 | Issued |
Array
(
[id] => 3692338
[patent_doc_number] => 05604248
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-02-18
[patent_title] => 'Method for minimizing the uterotrophic effect of tamoxifen and tamoxifen analogs'
[patent_app_type] => 1
[patent_app_number] => 8/239093
[patent_app_country] => US
[patent_app_date] => 1994-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3514
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/604/05604248.pdf
[firstpage_image] =>[orig_patent_app_number] => 239093
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/239093 | Method for minimizing the uterotrophic effect of tamoxifen and tamoxifen analogs | May 4, 1994 | Issued |
Array
(
[id] => 3729411
[patent_doc_number] => 05652255
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-07-29
[patent_title] => 'Potentiation of bioreductive agents'
[patent_app_type] => 1
[patent_app_number] => 8/235315
[patent_app_country] => US
[patent_app_date] => 1994-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 7
[patent_no_of_words] => 9410
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 165
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/652/05652255.pdf
[firstpage_image] =>[orig_patent_app_number] => 235315
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/235315 | Potentiation of bioreductive agents | Apr 28, 1994 | Issued |
Array
(
[id] => 3548195
[patent_doc_number] => 05545671
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-08-13
[patent_title] => 'Antimetastically acting agents'
[patent_app_type] => 1
[patent_app_number] => 8/234515
[patent_app_country] => US
[patent_app_date] => 1994-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 2991
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/545/05545671.pdf
[firstpage_image] =>[orig_patent_app_number] => 234515
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/234515 | Antimetastically acting agents | Apr 27, 1994 | Issued |
Array
(
[id] => 3692134
[patent_doc_number] => 05604233
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-02-18
[patent_title] => 'Lactone stable formulation of 7-ethyl camptothecin and methods for uses thereof'
[patent_app_type] => 1
[patent_app_number] => 8/234131
[patent_app_country] => US
[patent_app_date] => 1994-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10401
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 24
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/604/05604233.pdf
[firstpage_image] =>[orig_patent_app_number] => 234131
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/234131 | Lactone stable formulation of 7-ethyl camptothecin and methods for uses thereof | Apr 27, 1994 | Issued |
| 08/232404 | METHODS FOR ADMINISTRATION OF TAXOL | Apr 24, 1994 | Abandoned |
| 08/231717 | COMPOSITIONS AND METHODS FOR TREATING LEUKEMIA | Apr 21, 1994 | Abandoned |
Array
(
[id] => 3516810
[patent_doc_number] => 05576341
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-11-19
[patent_title] => '2-[[2-(N-isobutyl-N-methyl)amino]benzylsulfinyl]-benzimidazole as antimicrobial agent'
[patent_app_type] => 1
[patent_app_number] => 8/228750
[patent_app_country] => US
[patent_app_date] => 1994-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1222
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/576/05576341.pdf
[firstpage_image] =>[orig_patent_app_number] => 228750
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/228750 | 2-[[2-(N-isobutyl-N-methyl)amino]benzylsulfinyl]-benzimidazole as antimicrobial agent | Apr 17, 1994 | Issued |
Array
(
[id] => 3548140
[patent_doc_number] => 05545667
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-08-13
[patent_title] => 'Methods for treating neoplasms with betaines'
[patent_app_type] => 1
[patent_app_number] => 8/228912
[patent_app_country] => US
[patent_app_date] => 1994-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 7
[patent_no_of_words] => 6909
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/545/05545667.pdf
[firstpage_image] =>[orig_patent_app_number] => 228912
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/228912 | Methods for treating neoplasms with betaines | Apr 17, 1994 | Issued |
Array
(
[id] => 3589938
[patent_doc_number] => 05496807
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-03-05
[patent_title] => 'Method of treatment of diabetic nephropathy by means of sulodexide of medicines containing it'
[patent_app_type] => 1
[patent_app_number] => 8/227502
[patent_app_country] => US
[patent_app_date] => 1994-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2196
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/496/05496807.pdf
[firstpage_image] =>[orig_patent_app_number] => 227502
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/227502 | Method of treatment of diabetic nephropathy by means of sulodexide of medicines containing it | Apr 13, 1994 | Issued |
| 08/227616 | METHODS AND COMPOSITIONS FOR TREATING ESTROGEN-DEPENDENT DISEASES USING OPTICALLY PURE (-)-FADROZOLE | Apr 13, 1994 | Abandoned |
Array
(
[id] => 3658846
[patent_doc_number] => 05627171
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-05-06
[patent_title] => 'Sphingosine-1-phosphate/trimethylsphingosine composition'
[patent_app_type] => 1
[patent_app_number] => 8/225796
[patent_app_country] => US
[patent_app_date] => 1994-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 10
[patent_no_of_words] => 3437
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/627/05627171.pdf
[firstpage_image] =>[orig_patent_app_number] => 225796
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/225796 | Sphingosine-1-phosphate/trimethylsphingosine composition | Apr 10, 1994 | Issued |
Array
(
[id] => 3582640
[patent_doc_number] => 05580882
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-12-03
[patent_title] => 'Use of substituted quinoline carboxamide'
[patent_app_type] => 1
[patent_app_number] => 8/211579
[patent_app_country] => US
[patent_app_date] => 1994-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3551
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/580/05580882.pdf
[firstpage_image] =>[orig_patent_app_number] => 211579
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/211579 | Use of substituted quinoline carboxamide | Apr 7, 1994 | Issued |
| 08/224362 | TREATMENT OF H.PYLORI INFECTIONS | Apr 6, 1994 | Abandoned |